Alberta Investment Management Corporation »

Astria Therapeutics shares owned by Alberta Investment Management Corporation

Quarter-by-quarter ownership of Astria Therapeutics shares owned by Alberta Investment Management Corporation from 13F filings

Historical chart of Alberta Investment Management Corporation investment in Astria Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Astria Therapeutics held by Alberta Investment Management Corporation consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Astria Therapeutics by Alberta Investment Management Corporation

Quarter filed Position value Share count Share price at filing
2025-12-31 $3.6M 273k 13.09

More positions owned by Alberta Investment Management Corporation

Ishares Tr Core S&p500 Etf (IVV)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Rbc Cad (RY)
Toronto Dominion Bk Ont Com New (TD)
Western Digital Corp Note 3.000%11/1 (Principal)
Agnico (AEM)
Brookfield Corp Cl A Ltd Vt Sh (BN)
NVIDIA Corporation (NVDA)
Alphabet Cap Stk Cl A (GOOGL)
Enbridge (ENB)
Bank Of Montreal Cadcom (BMO)
Interdigital Note 3.500% 6/0 (Principal)
Bk Nova Cad (BNS)
Seagate Hdd Cayman Note 3.500% 6/0 (Principal)

View all positions for Alberta Investment Management Corporation

Top funds holding Astria Therapeutics

Perceptive Advisors
FMR
BlackRock
Glazer Capital
Millennium Management
Vanguard Group
UBS Group
Deutsche Bank Aktiengesellschaft
Jpmorgan Chase & Co
Driehaus Capital Management
Geode Capital Management
Nantahala Capital Management
Qube Research & Technologies
Omni Event Management
Man Group

View all funds holding Astria Therapeutics